Citations (104)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Anna Felis-Giemza, Magdalena Massalska, Leszek Roszkowski, Katarzyna Romanowska-Próchnicka & Marzena Ciechomska. (2023) Potential Mechanism of Fatigue Induction and Its Management by JAK Inhibitors in Inflammatory Rheumatic Diseases. Journal of Inflammation Research 16, pages 3949-3965.
Read now
Read now
Valgerdur Sigurdardottir, Anna Engstrom, Patric Berling, Tor Olofsson, Linnea Oldsberg, Susannah Sadler, Devian Parra-Padilla, Lode Melis & Damon Willems. (2023) Cost-effectiveness analysis of bimekizumab for the treatment of active psoriatic arthritis in Sweden. Journal of Medical Economics 26:1, pages 1190-1200.
Read now
Read now
Rubén Queiro, Marta Loredo, Ignacio Braña, Estefanía Pardo, Sara Alonso & Mercedes Alperi. (2023) Managing psoriatic arthritis in different clinical scenarios. Expert Review of Clinical Immunology 19:12, pages 1469-1484.
Read now
Read now
AJ Landgren, E Klingberg, LTH Jacobsson, U Bergsten & M Dehlin. (2023) Health-related quality of life in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis, results from a cross-sectional survey in Western Sweden. Scandinavian Journal of Rheumatology 52:5, pages 506-518.
Read now
Read now
Roaa Aljohani. (2022) Metabolic Syndrome and Its Components in Psoriatic Arthritis. Open Access Rheumatology: Research and Reviews 14, pages 7-16.
Read now
Read now
Mihaela Ionela Sarbu, Nicolae Sarbu, Doriana Cristea Ene, Daniela Corche, Radu Baz, Dragos Negru, Aurel Nechita, Silvia Fotea, Lucretia Anghel & Alin Laurentiu Tatu. (2021) New Perspectives on Diagnosing Psoriatic Arthritis by Imaging Techniques. Open Access Rheumatology: Research and Reviews 13, pages 343-352.
Read now
Read now
Maria Sole Chimenti, Arianna D’Antonio, Paola Conigliaro, Sara Ferrigno, Andrea Vendola, Mario Ferraioli, Paola Triggianese, Luisa Costa, Francesco Caso & Roberto Perricone. (2020) An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis. Biologics: Targets and Therapy 14, pages 53-75.
Read now
Read now
Vinod Chandran. (2020) Pathway to biomarker discovery in psoriatic arthritis. Expert Review of Clinical Immunology 16:5, pages 471-478.
Read now
Read now
Vinod Chandran & Proton Rahman. (2020) Predicting therapeutic response through biomarker analysis in psoriatic arthritis, an example of precision medicine. Expert Review of Precision Medicine and Drug Development 5:1, pages 35-42.
Read now
Read now
Manfred Harth & Warren R. Nielson. (2019) Pain and affective distress in arthritis: relationship to immunity and inflammation. Expert Review of Clinical Immunology 15:5, pages 541-552.
Read now
Read now
Articles from other publishers (94)
Branko Ristic, Antonio Carletto, Elena Fracassi, Giulio Pacenza, Giulia Zanetti, Francesca Pistillo, Doriana Cristofalo, Riccardo Bixio, Chiara Bonetto & Sarah Tosato. (2023) Comparison and potential determinants of health-related quality of life among rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: A cross-sectional study. Journal of Psychosomatic Research 175, pages 111512.
Crossref
Crossref
Natalie Frede, Sonja Hiestand, Franziska Schauer, Dominique Endres, Ludger Tebartz van Elst, Markus Zeisbrich, Nils Craig-Mueller, Stephanie Finzel, Jens Thiel, Reinhard E. Voll, Christoph Schempp & Nils Venhoff. (2023) Psoriasis and Psoriatic Arthritis Have a Major Impact on Quality of Life and Depressive Symptoms: A Cross-Sectional Study of 300 Patients. Rheumatology and Therapy 10:6, pages 1655-1668.
Crossref
Crossref
Ryuichi Ohta & Chiaki Sano. (2023) Challenges in Diagnosing Psoriatic Arthritis in Primary Care: A Meta-Ethnographic Study. Cureus.
Crossref
Crossref
Renaud Felten, Laura Widawski, Lionel Spielmann, Corine Gaillez, Weibin Bao, Jacques-Eric Gottenberg, Pierre-Marie Duret & Laurent Messer. (2023) Impact of hyperuricaemia on patients with psoriatic arthritis treated with secukinumab in the FUTURE 2–5 and MAXIMISE studies. RMD Open 9:4, pages e003428.
Crossref
Crossref
Ying Ying Leung, Lihi Eder, Ana-Maria Orbai, Laura C Coates, Maarten de Wit, Josef S Smolen, Uta Kiltz, Penélope Palominos, Juan D Canete, Rossana Scrivo, Andra Balanescu, Emanuelle Dernis, Sandra Meisalu, Martin Soubrier, Umut Kalyoncu & Laure Gossec. (2023) Association between obesity and likelihood of remission or low disease activity status in psoriatic arthritis applying index-based and patient-based definitions of remission: a cross-sectional study. RMD Open 9:3, pages e003157.
Crossref
Crossref
Yin Pin Loo, Chai Har Loo, Ai Lee Lim, Chee Keong Wong, Norazlima Binti Mohd Ali, Yek Huan Khor & Wooi Chiang Tan. (2023) Prevalence and risk factors associated with psoriatic arthritis among patients with psoriasis. International Journal of Rheumatic Diseases 26:9, pages 1788-1798.
Crossref
Crossref
Karl Gaffney, Nicola Gullick, Kirsten MacKay, Yusuf Patel, Raj Sengupta, Tom Sheeran, Louise Hemmings & Paula Pamies. (2023) Real-world evidence for secukinumab in UK patients with psoriatic arthritis or radiographic axial spondyloarthritis: interim 2-year analysis from SERENA. Rheumatology Advances in Practice 7:3.
Crossref
Crossref
Faten Hamitouche, Clementina Lopez-Medina, Laure Gossec, Serge Perrot, Maxime Dougados & Anna Moltó. (2023) Evaluation of the agreement between the ACR 1990 fibromyalgia tender points and an enthesitis score in patients with axial spondyloarthritis. Rheumatology 62:8, pages 2757-2764.
Crossref
Crossref
Gamze Kılıç, Erkan Kılıç, İbrahim Tekeoğlu, Betül Sargın, Gizem Cengiz, Nihan Cüzdan Balta, Hakan Alkan, Sevtap Acer Kasman, Nilay Şahin, Kevser Orhan, İlknur Albayrak Gezer, Dilek Keskin, Cevriye Mülkoğlu, Hatice Reşorlu, Şebnem Ataman, Ajda Bal, Mehmet Tuncay Duruöz, Okan Küçükakkaş, Nesrin Şen, Murat Toprak, Ozan Volkan Yurdakul, Meltem Alkan Melikoğlu, Fikriye Figen Ayhan, Merve Baykul, Hatice Bodur, Mustafa Çalış, Erhan Çapkın, Gül Devrimsel, Sami Hizmetli, Ayhan Kamanlı, Yaşar Keskin, Hilal Ecesoy, Öznur Kutluk, Ömer Faruk Şendur, Sena Tolu, Tiraje Tuncer & Kemal Nas. (2023) Beyond expectations: disease duration and psychological burden in psoriatic arthritis. Rheumatology International 43:9, pages 1695-1704.
Crossref
Crossref
Laure Gossec, Elke Theander, Soumya D. Chakravarty, Paul Bergmans, Frederic Lavie, Wim Noël, Mohamed Sharaf, Stefan Siebert & Josef S. Smolen. (2023) Response to treatment in psoriatic arthritis, the effect of age: analysis of patients receiving ustekinumab in the PsABio real-world study. Arthritis Research & Therapy 25:1.
Crossref
Crossref
Himanshu Pathak, Mohit Goyal, Parthajit Das, Sham Santhanam, Ajaz Kariem Khan, Sourabh Malaviya, Akshat Pandey, Pravin Patil, Bimlesh Dhar Pandey, Prasandeep Rath, Swetal Pandey, Neeraj Jain, Somya Jain, Amit Dua, Anshul Goel, Damodaran Potikuri, Arun Kumar Kedia & Vinod Ravindran. (2023) Awareness, perspectives and satisfaction levels among patients with psoriatic arthritis: a multicentric cross-sectional survey. Rheumatology International 43:8, pages 1531-1539.
Crossref
Crossref
Francesco Salvatore Iaquinta, Daniele Mauro, Ilenia Pantano, Saverio Naty, Daniela Iacono, Emanuela Gaggiano, Luca Riccio, Francesco Ciccia, Rosa Daniela Grembiale & Rocco Spagnuolo. (2023) Gastrointestinal Symptoms Impact Psychosocial Function and Quality of Life in Patients with Rheumatoid Arthritis and Spondyloarthritis: A Cross-Sectional Study. Journal of Clinical Medicine 12:9, pages 3248.
Crossref
Crossref
Marlene Sousa, Ennio Lubrano, Josef S. Smolen, Clémence Gorlier, Maarten de Wit, Laura C. Coates, Umut Kalyoncu, Adeline Ruyssen-Witrand, Ying-Ying Leung, Rossana Scrivo, Juan D. Cañete, Penelope Palominos, Sandra Meisalu, Andra Balanescu, Uta Kiltz, Sibel Zehra Aydin, Inna Gaydukova, Emmanuelle Dernis, Bruno Fautrel, Ana-Maria Orbai & Laure Gossec. (2023) Patient-defined flares and disease activity worsening in 222 patients with psoriatic arthritis from 14 countries. Joint Bone Spine 90:3, pages 105511.
Crossref
Crossref
С. І. Сміян, А. В. Білуха & Л. В. Балабан. (2023) СТАН ВАЗОРЕГУЛЮВАЛЬНОЇ ФУНКЦІЇ ЕНДОТЕЛІЮ У ХВОРИХ НА ПСОРІАТИЧНИЙ АРТРИТ. Здобутки клінічної і експериментальної медицини:1, pages 168-175.
Crossref
Crossref
Laure Gossec, Jessica A. Walsh, Kaleb Michaud, Steve Peterson, Elizabeth A. Holdsworth, Chetan S. Karyekar, Nicola Booth, Soumya D. Chakravarty & Alexis Ogdie. (2023) Women With Psoriatic Arthritis Experience Higher Disease Burden Than Men: Findings From a Real-World Survey in the United States and Europe. The Journal of Rheumatology 50:2, pages 192-196.
Crossref
Crossref
Philip J Mease, Akihiko Asahina, Dafna D Gladman, Yoshiya Tanaka, William Tillett, Barbara Ink, Deepak Assudani, Christine de la Loge, Jason Coarse, Jason Eells & Laure Gossec. (2023) Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE. Rheumatology 62:2, pages 617-628.
Crossref
Crossref
Lars Erik Kristensen, Ahmed M Soliman, Kim Papp, Douglas White, Lisa Barcomb, Wenjing Lu, Ann Eldred & Frank Behrens. (2023) Risankizumab improved health-related quality of life, fatigue, pain and work productivity in psoriatic arthritis: results of KEEPsAKE 1. Rheumatology 62:2, pages 629-637.
Crossref
Crossref
Emilce E. Schneeberger, Gustavo Citera, Peter Nash, Josef S. Smolen, Philip J. Mease, Enrique R. Soriano, Claudia Helling, Annette E. Szumski, Rajiv Mundayat & Darío Ponce de León. (2023) Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofacitinib studies. Seminars in Arthritis and Rheumatism 58, pages 152134.
Crossref
Crossref
Sara Alonso-Castro, Andrea García-Valle, Isla Morante-Bolado, Ignacio Braña, Estefanía Pardo & Rubén Queiro. (2023) Differentiated Effect of Smoking on Disease Activity and Quality of Life among Different Spondyloarthritis Phenotypes. Journal of Clinical Medicine 12:2, pages 551.
Crossref
Crossref
Ana-Maria Orbai, William Tillett, Suzanne Grieb, Steve Peterson, Elizabeth A. Holdsworth, Nicola Booth, Soumya D. Chakravarty & Laure Gossec. (2023) Impact of Physician-Defined Flares on Quality of Life and Work Impairment: An International Survey of 2238 Patients With Psoriatic Arthritis. The Journal of Rheumatology 50:1, pages 76-83.
Crossref
Crossref
Lia N PizzicatoAisha VadhariyaJulie BirtAmita Girish KetkarRebecca BolceMichael GrabnerRebecca S PepeJessica A Walsh. (2023) Real-world treatment patterns and use of adjunctive pain and anti-inflammatory medications among patients with psoriatic arthritis treated with IL-17A inhibitors in the United States. Journal of Managed Care & Specialty Pharmacy 29:1, pages 24-35.
Crossref
Crossref
April W. Armstrong, Barbra Bohannan, Sicily Mburu, Laura C. Coates, Alexis Ogdie, Ivette Alarcon, Torben Kasparek, Susan Frade, Silvia Fernandez Barrio & Matthias Augustin. (2023) Patient Perspectives on Psoriatic Disease Burden: Results from the Global Psoriasis and Beyond Survey. Dermatology 239:4, pages 621-634.
Crossref
Crossref
Xiaomei Leng, Wei Lin, Shixue Liu, Keith Kanik, Cunshan Wang, Weiguo Wan, Zhenyu Jiang, Yi Liu, Shengyun Liu, Zhuoli Zhang, Zhiyi Zhang, Jian Xu, Wenfeng Tan, Jiankang Hu, Jingyang Li, Ju Liu, Levent M. Gunay, Oluwaseyi Dina, Cassandra Kinch & Xiaofeng Zeng. (2023) Efficacy and safety of tofacitinib in Chinese patients with active psoriatic arthritis: a phase 3, randomised, double-blind, placebo-controlled study. RMD Open 9:1, pages e002559.
Crossref
Crossref
Esra Ağaoğlu, Hilal Kaya Erdoğan, Ersoy Acer & Zeynep Nurhan Saraçoğlu. (2022) Do Dermatological Diseases Cause Disability? A Single Tertiary Center Experience. European Archives of Medical Research 38:4, pages 255-260.
Crossref
Crossref
K. Reich, K.B. Gordon, B. Strober, R.G. Langley, M. Miller, Y.‐W. Yang, Y.‐K. Shen, Y. You, Y. Zhu, P. Foley & A. Blauvelt. (2022) Super‐response to guselkumab treatment in patients with moderate‐to‐severe psoriasis: age, body weight, baseline Psoriasis Area and Severity Index, and baseline Investigator's Global Assessment scores predict complete skin clearance. Journal of the European Academy of Dermatology and Venereology 36:12, pages 2393-2400.
Crossref
Crossref
Georg Gross, Christian Lull, Jan von Ahnen, Victor Olsavszky, Johannes Knitza, Astrid Schmieder & Jan Leipe. (2022) German Mobile Apps for Patients with Psoriatic Arthritis: Systematic App Search and Content Analysis. Health Policy and Technology 11:4, pages 100697.
Crossref
Crossref
Laura C. Coates, Iain B. McInnes, Joseph F. Merola, Richard B. Warren, Arthur Kavanaugh, Alice B. Gottlieb, Laure Gossec, Deepak Assudani, Rajan Bajracharya, Jason Coarse, Barbara Ink & Christopher T. Ritchlin. (2022)
Safety and Efficacy of Bimekizumab in Patients With Active Psoriatic Arthritis:
Three‐Year
Results From a Phase
IIb
Randomized Controlled Trial and Its
Open‐Label
Extension Study
. Arthritis & Rheumatology 74:12, pages 1959-1970.
Crossref
Crossref
L.E. Kristensen, A.M. Soliman, K. Papp, L. Barcomb, A. Eldred & A. Östör. (2022) The effect of risankizumab on achieving minimal clinically important differences in patient‐reported outcomes in patients with psoriatic arthritis: results from KEEPsAKE 1 and 2. Journal of the European Academy of Dermatology and Venereology 36:11, pages 2120-2129.
Crossref
Crossref
Ana-Maria Orbai, Laura C. Coates, Atul Deodhar, Philip S. Helliwell, Christopher T. Ritchlin, Evan Leibowitz, Alexa P. Kollmeier, Elizabeth C. Hsia, Xie L. Xu, Shihong Sheng, Yusang Jiang, Yan Liu & Chenglong Han. (2022) Meaningful Improvement in General Health Outcomes with Guselkumab Treatment for Psoriatic Arthritis: Patient-Reported Outcomes Measurement Information System-29 Results from a Phase 3 Study. The Patient - Patient-Centered Outcomes Research 15:6, pages 657-668.
Crossref
Crossref
Rubén Queiro, Sara Alonso, Isla Morante & Mercedes Alperi. (2022) Non-Physical Disease Facets in Spondyloarthritis: An ASAS Health Index-Based Analysis between Psoriatic Arthritis and Axial Spondyloarthritis. Journal of Clinical Medicine 11:20, pages 6094.
Crossref
Crossref
Fazira R. Kasiem, Annelieke Pasma, Jolanda J. Luime, Ilja Tchetverikov, Kim Wervers, Lindy-Anne Korswagen, Natasja Denissen, Yvonne P.M. Goekoop-Ruiterman, Maikel van Oosterhout, Faouzia Fodili, Johanna M.W. Hazes, Martijn B.A. van Doorn, Marc R. Kok & Marijn Vis,. (2022) A Practical Guide for Assessment of Skin Burden in Patients With Psoriatic Arthritis. The Journal of Rheumatology 49:10, pages 1117-1123.
Crossref
Crossref
Florian Lucasson, Andra Balanescu, Uta Kiltz, Ying-Ying Leung, Sibel Zehra Aydin, Inna Gaydukova, Ennio Lubrano, Laura C. Coates, Maarten de Wit, Ana-Maria Orbai & Laure Gossec. (2022) Residual patient-reported burden in 444 patients with psoriatic arthritis in remission or low disease: A cross-sectional analysis. Joint Bone Spine 89:5, pages 105372.
Crossref
Crossref
Kurt de Vlam, Philip J. Mease, Andrew G. Bushmakin, Roy Fleischmann, Alexis Ogdie, Valderilio F. Azevedo, Joseph F. Merola, John Woolcott, Joseph C. Cappelleri, Lara Fallon & Peter C. Taylor. (2022) Identifying and Quantifying the Role of Inflammation in Pain Reduction for Patients With Psoriatic Arthritis Treated With Tofacitinib: A Mediation Analysis. Rheumatology and Therapy 9:5, pages 1451-1464.
Crossref
Crossref
Alexis OgdieMark HwangPhani VeerankiAlexandria PortelliSteven SisonJason ShafrinSofia PedroSteven HassPeter HurNina KimEsther YiKaleb Michaud. (2022) Health care utilization and costs associated with functional status in patients with psoriatic arthritis. Journal of Managed Care & Specialty Pharmacy 28:9, pages 997-1007.
Crossref
Crossref
Stacie Hudgens, Cristian Gugiu, Aiste Guobyte, Ahmed M. Soliman, Kristina A. Fitzgerald, Lisa M. Barcomb, Ann K. Eldred & Martin M. Okun. (2022) Validation of the Physician’s Global Assessment of Fingernail Psoriasis by Rheumatologists Treating Psoriatic Arthritis. Value in Health 25:9, pages 1582-1589.
Crossref
Crossref
Laura Tucker, Alexander Allen, David Chandler, Coziana Ciurtin, Andrew Dick, Amy Foulkes, Nicola Gullick, Philip Helliwell, Deepak Jadon, Gareth Jones, Stuart Kyle, Vishnu Madhok, Neil McHugh, Andrew Parkinson, Tim Raine, Stefan Siebert, Catherine Smith, William Tillett & Laura C Coates. (2022) The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs. Rheumatology 61:9, pages e255-e266.
Crossref
Crossref
Tamara W. van Hal, Michelle L. M. Mulder, Mark H. Wenink & Johanna E. Vriezekolk. (2022) Determinants of work and social participation in patients with psoriatic arthritis in the Netherlands: an observational study. BMC Rheumatology 6:1.
Crossref
Crossref
Rocco Spagnuolo, Francesco Salvatore Iaquinta, Daniele Mauro, Ilenia Pantano, Stefano Dastoli, Saverio Naty, Cristina Cosco, Rosellina Margherita Mancina, Daniela Iacono, Emanuela Gaggiano, Annarita Ruggiero, Steven Paul Nisticò, Francesco Ciccia, Rosa Daniela Grembiale & Doldo Patrizia. (2022) Satisfaction with Social Roles and Physical Function in Immune-mediated
Inflammatory Diseases: A Cross-Sectional Study. Reviews on Recent Clinical Trials 17:3, pages 177-186.
Crossref
Crossref
Suzan Attar, Amjad M Almanmmas, Shabab M Alamri, Ahmad W Sindi, Majed T Jobah, Marwan A Bader, Abdulrahman K Alghamdi, Majd Z Sahhaf & Turki A AlAmoudi. (2022) Burden and Disease Characteristics of Psoriatic Arthritis Among King Abdulaziz University Hospital Patients. Cureus.
Crossref
Crossref
Christian Dejaco, Thomas Mueller, Omid Zamani, Ulrike Kurtz, Stefan Egger, Johannes Resch-Passini, Anna Totzauer, Babak Yazdani-Biuki, Thomas Schwingenschloegl, Peter Peichl, Angelika Kraus & Gerhard W. Naerr. (2022) A Prospective Study to Evaluate the Impact of Golimumab Therapy on Work Productivity and Activity, and Quality of Life in Patients With Rheumatoid Arthritis, Psoriasis Arthritis and Axial Spondyloarthritis in a Real Life Setting in AUSTRIA. The GO-ACTIVE Study. Frontiers in Medicine 9.
Crossref
Crossref
Pascal Richette, Laura C. Coates, Valderilio F. Azevedo, Joseph C. Cappelleri, Jade Moser, Ruben Queiro-Silva, Lara Fallon & Meriem Kessouri. (2022) Patient Perception of Medical Care for Psoriatic Arthritis in North America and Europe: Results from a Global Patient Survey. Rheumatology and Therapy 9:3, pages 823-838.
Crossref
Crossref
Melanie Sloan, Elliott Lever, Rupert Harwood, Caroline Gordon, Chris Wincup, Moira Blane, James Brimicombe, Peter Lanyon, Paul Howard, Stephen Sutton, David D’Cruz & Felix Naughton. (2022) Telemedicine in rheumatology: a mixed methods study exploring acceptability, preferences and experiences among patients and clinicians. Rheumatology 61:6, pages 2262-2274.
Crossref
Crossref
Panagiotis Athanassiou, Anastasios Kotrotsios, Ioannis Kallitsakis, Andreas Bounas, Theodoros Dimitroulas, Alexandros Garyfallos, Maria G. Tektonidou, Giorgos Vosvotekas, Achilleas Livieratos, Evangelia Petrikkou & Gkikas Katsifis. (2021) The effects of golimumab on work productivity and quality of life among work-active axial spondyloarthritis and psoriatic arthritis patients treated in the routine care in Greece: the ‘GO-UP’ study. Quality of Life Research 31:5, pages 1385-1399.
Crossref
Crossref
Alice B. Gottlieb, Alvin F. Wells & Joseph F. Merola. (2022) Telemedicine and psoriatic arthritis: best practices and considerations for dermatologists and rheumatologists. Clinical Rheumatology 41:5, pages 1271-1283.
Crossref
Crossref
Svitlana Smiyan, Anastasya Bilukha, Bohdan Koshak, Oleh Hrymalyuk & Viktoria Smiyan. (2022) COVID-19 in Patients with Psoriatic Arthritis. Family medicine:1-2, pages 43-47.
Crossref
Crossref
Francesco Salvatore Iaquinta, Rosa Daniela Grembiale, Daniele Mauro, Ilenia Pantano, Saverio Naty, Cristina Cosco, Daniela Iacono, Emanuela Gaggiano, Annarita Ruggiero, Francesco Ciccia, Patrizia Doldo & Rocco Spagnuolo. (2022) Fatigue and Associated Factors in an Immune-Mediated Inflammatory Disease Population: A Cross-Sectional Study. Journal of Clinical Medicine 11:9, pages 2455.
Crossref
Crossref
Fazira R Kasiem, Marc R Kok, Jolanda J Luime, Ilja Tchetverikov, Kim Wervers, Lindy-Anne Korswagen, Nastasja H A M Denissen, Yvonne P M Goekoop-Ruiterman, Maikel van Oosterhout, Faouzia Fodili, Johanna M W Hazes & Marijn Vis. (2022) The burden of psoriasis in patients with early psoriatic arthritis. Rheumatology 61:4, pages 1570-1578.
Crossref
Crossref
Freddy Lättekivi, Irina Guljavina, Getnet Midekessa, Janeli Viil, Paul R. Heath, Rikke Bæk, Malene Møller Jørgensen, Aneta Andronowska, Kulli Kingo & Alireza Fazeli. (2022) Profiling Blood Serum Extracellular Vesicles in Plaque Psoriasis and Psoriatic Arthritis Patients Reveals Potential Disease Biomarkers. International Journal of Molecular Sciences 23:7, pages 4005.
Crossref
Crossref
Christopher T Ritchlin, Philip J Mease, Wolf-Henning Boehncke, John Tesser, Elena Schiopu, Soumya D Chakravarty, Alexa P Kollmeier, Xie L Xu, May Shawi, Yusang Jiang, Shihong Sheng, Yanli Wang, Stephen Xu, Joseph F Merola, Iain B McInnes & Atul Deodhar. (2022) Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: pooled results through week 52 of two phase III, randomised, placebo-controlled studies. RMD Open 8:1, pages e002195.
Crossref
Crossref
Maurizio Benucci, Arianna Damiani, Maria Infantino, Mariangela Manfredi, Barbara Lari, Valentina Grossi, Elena Biancamaria Mariotti, Alberto Corrà, Cristina Aimo, Lavinia Quintarelli, Alice Verdelli, Francesca Li Gobbi, Emiliano Antiga & Marzia Caproni. (2022) Vaccination for SARS-CoV-2 in Patients With Psoriatic Arthritis: Can Therapy Affect the Immunological Response?. Frontiers in Medicine 9.
Crossref
Crossref
Kurt de Vlam, Adrien Nzeusseu Toukap, Marie-Joëlle Kaiser, Johan Vanhoof, Philip Remans, Marthe Van den Berghe, Silvana Di Romana, Filip Van den Bosch & Rik Lories. (2022) Real-World Efficacy and Safety of Apremilast in Belgian Patients with Psoriatic Arthritis: Results from the Prospective Observational APOLO Study. Advances in Therapy 39:2, pages 1055-1067.
Crossref
Crossref
K.M. Koreshkova & Z.R. Khismatullina. (2022) Quality of life in psoriatic arthritis: review of selected assessment methods and their results. Klinicheskaya dermatologiya i venerologiya 21:1, pages 15.
Crossref
Crossref
Georgios Kokolakis, Kasper Vadstrup, Jes B. Hansen & Jose Manuel Carrascosa. (2022) Brodalumab Is Associated with High Rates of Complete Clearance and Quality of Life Improvement: A Subgroup Analysis of Patients with Psoriasis and Concomitant Psoriatic Arthritis. Dermatology 238:4, pages 620-629.
Crossref
Crossref
Florian Lucasson, Pascal Richette, Krystel Aouad, Adeline Ryussen-Witrand, Daniel Wendling, Bruno Fautrel & Laure Gossec. (2022) Prevalence and consequences of psoriasis in recent axial spondyloarthritis: an analysis of the DESIR cohort over 6 years. RMD Open 8:1, pages e001986.
Crossref
Crossref
Achala Liyanage, G. Liyanage, V. De Silva, J. Akarawita, C. Gunasekera, S. Imafuku & S. Lekamwasam. (2021) Validation of psoriasis disability index (PDI) questionnaire Sinhala version. Archives of Dermatological Research 314:1, pages 61-69.
Crossref
Crossref
Laura C. Coates, Andrew G. Bushmakin, Oliver FitzGerald, Dafna D. Gladman, Lara Fallon, Joseph C. Cappelleri, Ming-Ann Hsu & Philip S. Helliwell. (2021) Relationships between psoriatic arthritis composite measures of disease activity with patient-reported outcomes in phase 3 studies of tofacitinib. Arthritis Research & Therapy 23:1.
Crossref
Crossref
Felipe A. Moraes, Michael R.R. da Silva, Jéssica B.R. dos Santos, Francisco A. Acurcio, Alessandra M. Almeida, Adriana M. Kakehasi & Juliana Alvares-Teodoro. (2021) Health-Related Quality of Life in Psoriatic Arthritis: Findings and Implications. Value in Health Regional Issues 26, pages 135-141.
Crossref
Crossref
Vibeke Strand, Philip J. Mease, Enrique R. Soriano, Mitsumasa Kishimoto, Carlo Salvarani, Christopher D. Saffore, Patrick Zueger, Erin McDearmon-Blondell, Koji Kato & Dafna D. Gladman. (2021) Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1. Rheumatology and Therapy 8:4, pages 1789-1808.
Crossref
Crossref
Laura C. Coates, Valderilio F. Azevedo, Joseph C. Cappelleri, Jade Moser, Lihi Eder, Pascal Richette, Meng-Yu Weng, Ruben Queiro Silva, Amit Garg, Amar Majjhoo, Christopher E. M. Griffiths, Pamela Young & Samantha Howland. (2021) Exploring the Quality of Communication Between Patients with Psoriatic Arthritis and Physicians: Results of a Global Online Survey. Rheumatology and Therapy 8:4, pages 1741-1758.
Crossref
Crossref
Chrysoula G. Gialouri & George E. Fragoulis. (2021) Disease activity indices in psoriatic arthritis: current and evolving concepts. Clinical Rheumatology 40:11, pages 4427-4435.
Crossref
Crossref
Lucia Novelli, Ennio Lubrano, Vincenzo Venerito, Fabio Massimo Perrotta, Francesca Marando, Giacomo Curradi & Florenzo Iannone. (2021) Extra-Articular Manifestations and Comorbidities in Psoriatic Disease: A Journey Into the Immunologic Crosstalk. Frontiers in Medicine 8.
Crossref
Crossref
Peter C. Taylor, Andrew G. Bushmakin, Joseph C. Cappelleri, Pamela Young, Rebecca Germino, Joseph F. Merola & Gil Yosipovitch. (2021) Itch as Major Mediator of Effect of Tofacitinib on Health-Related Quality of Life in Psoriatic Arthritis: A Mediation Analysis. Journal of Clinical Medicine 10:18, pages 4081.
Crossref
Crossref
Mariana Garcia-Leal, Mayra A. Reyes-Soto, Ivan Hernandez-Galarza, Neri A. Alvarez-Villalobos, Dionicio A. Galarza-Delgado & Diana E. Flores-Alvarado. (2021) Does current evidence on disease-modifying antirheumatic drugs for psoriatic arthritis reinforce an effect on radiographic progression? Results from a systematic review and meta-analysis. Clinical Rheumatology 40:9, pages 3499-3510.
Crossref
Crossref
Marie Skougaard, Tanja S Jørgensen, Mia J Jensen, Christine Ballegaard, Jørgen Guldberg-Møller, Alexander Egeberg, Robin Christensen, Peter Benzin, Zara R Stisen, Joseph F Merola, Laura C Coates, Vibeke Strand, Phillip Mease & Lars Erik Kristensen. (2021) Change in psoriatic arthritis outcome measures impacts SF-36 physical and mental component scores differently: an observational cohort study. Rheumatology Advances in Practice 5:3.
Crossref
Crossref
Krystel Aouad, Georgia Moysidou, Antsa Rakotozafiarison, Bruno Fautrel & Laure Gossec. (2021) Outcome measures used in psoriatic arthritis registries and cohorts: A systematic literature review of 27 registries or 16,183 patients. Seminars in Arthritis and Rheumatism 51:4, pages 888-894.
Crossref
Crossref
Shimaa Badr, Mowaffak M. Saad, Abdelmoneim Helal, Hamdy Koraym, Manal Tayel, Ihab Reda, Khaled Matrawy & Yousra Hisham Abdel Fattah. (2021) Quality of life and its relation to periarticular bone changes in psoriatic patients with or without joint involvement. Clinical Rheumatology 40:8, pages 3175-3183.
Crossref
Crossref
Achala Liyanage, S. Verni, G. Liyanage, V. De Silva, J. Akarawita, C. Gunasekera, J. Rubasinghe, S. Imafuku & S. Lekamwasam. (2021) Validation of Sinhala version of Psoriasis Epidemiology Screening Tool. Clinical Rheumatology 40:8, pages 3127-3134.
Crossref
Crossref
Kurt de Vlam, Alexis Ogdie, Andrew G Bushmakin, Joseph C Cappelleri, Roy Fleischmann, Peter C Taylor, Valderilio Azevedo, Lara Fallon, John Woolcott & Philip J Mease. (2021) Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib. RMD Open 7:2, pages e001609.
Crossref
Crossref
Arani Vivekanantham, Dylan McGagh & Laura C. Coates. (2021) Current treatments and recommendations for Psoriatic Arthritis. Best Practice & Research Clinical Rheumatology 35:2, pages 101680.
Crossref
Crossref
Philip J Mease, Iain B McInnes, Lai-Shan Tam, Kiefer Eaton, Steve Peterson, Agata Schubert, Soumya D Chakravarty, Anna Parackal, Chetan S Karyekar, Sandhya Nair, Wolf-Henning Boehncke & Christopher Ritchlin. (2021) Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysis. Rheumatology 60:5, pages 2109-2121.
Crossref
Crossref
Vanessa L. Ramos & Abby S. Van Voorhees. (2021) Guidelines for Management of Psoriasis. Journal of the Dermatology Nurses' Association 13:3, pages 168-174.
Crossref
Crossref
Penélope Esther Palominos, Laura Coates, Charles Lubianca Kohem, Ana-Maria Orbai, Josef Smolen, Maarten de Wit, Uta Kiltz, Ying-Ying Leung, Juan D. Cañete, Rossana Scrivo, Andra Balanescu, Emmanuelle Dernis, Sandra Meisalu, Martin Soubrier, Sibel Zehra Aydin, Inna Gaydukova, Umut Kalyoncu & Laure Gossec. (2021) Les déterminants des troubles du sommeil dans le rhumatisme psoriasique : étude observationnelle portant sur 696 patients de 14 pays. Revue du Rhumatisme 88:3, pages 201-207.
Crossref
Crossref
Philip J. Mease, Mei Liu, Sabrina Rebello, Robert R. McLean, Blessing Dube, Meghan Glynn, Peter Hur & Alexis Ogdie. (2021) Association of Nail Psoriasis With Disease Activity Measures and Impact in Psoriatic Arthritis: Data From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry. The Journal of Rheumatology 48:4, pages 520-526.
Crossref
Crossref
Jordi Gratacós Masmitjà, Carlos M. González Fernández, Susana Gómez Castro & Francisco José Rebollo Laserna. (2020) Efficacy of Tofacitinib in the Treatment of Psoriatic Arthritis: A Systematic Review. Advances in Therapy 38:2, pages 868-884.
Crossref
Crossref
Anna Ścisłowska-Czarnecka, Aleksandra Matuła, Aneta Bac, Amelia Lizak & Monika Wilk. (2020) Selected therapeutic methods affecting the health and quality of life of chronically dermatologically ill people. Health Promotion & Physical Activity 13:4, pages 51-61.
Crossref
Crossref
Glenn Haugeberg, Mari Hoff, Arthur Kavanaugh & Brigitte Michelsen. (2020) Psoriatic arthritis: exploring the occurrence of sleep disturbances, fatigue, and depression and their correlates. Arthritis Research & Therapy 22:1.
Crossref
Crossref
L. C. Coates, A.-M. Orbai, V. F. Azevedo, J. C. Cappelleri, K. Steinberg, R. Lippe, I. Lim, L. Eder, P. Richette, M. Y. Weng, R. Queiro Silva & L. Fallon. (2020) Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire. Health and Quality of Life Outcomes 18:1.
Crossref
Crossref
J.F. Merola, K.A. Papp, P. Nash, J. Gratacós, W.H. Boehncke, D. Thaçi, D. Graham, M‐A. Hsu, C. Wang, J. Wu & P. Young. (2020) Tofacitinib in psoriatic arthritis patients: skin signs and symptoms and health‐related quality of life from two randomized phase 3 studies. Journal of the European Academy of Dermatology and Venereology 34:12, pages 2809-2820.
Crossref
Crossref
Є. Д. Єгудіна & С. А. Трипілка. (2020) Management of Patients with Psoriatic Arthritis – Analysis and Discussion of the Main Points of the EULAR Recommendations 2019. Family medicine:4, pages 15-27.
Crossref
Crossref
Alexis Ogdie, Kaleb Michaud, Miroslawa Nowak, Rachel Bruce, Sarah Cantor, Carlijn Hintzen & Philip J Mease. (2020) Patient’s experience of psoriatic arthritis: a conceptual model based on qualitative interviews. RMD Open 6:3, pages e001321.
Crossref
Crossref
Penélope Esther Palominos, Laura Coates, Charles Lubianca Kohem, Ana-Maria Orbai, Josef Smolen, Maarten de Wit, Uta Kiltz, Ying-Ying Leung, Juan D. Cañete, Rossana Scrivo, Andra Balanescu, Emmanuelle Dernis, Sandra Meisalu, Martin Soubrier, Sibel Zehra Aydin, Inna Gaydukova, Umut Kalyoncu & Laure Gossec. (2020) Determinants of sleep impairment in psoriatic arthritis: An observational study with 396 patients from 14 countries. Joint Bone Spine 87:5, pages 449-454.
Crossref
Crossref
Laure Gossec. (2020) Le rhumatisme psoriasique : un sujet en évolution !. Revue du Rhumatisme Monographies 87:4, pages 243-244.
Crossref
Crossref
Tania Gudu & Laure Gossec. (2020) Impact du rhumatisme psoriasique sur la qualité de vie. Revue du Rhumatisme Monographies 87:4, pages 288-294.
Crossref
Crossref
Gizem Ayan, Dilek Solmaz, Sibel Bakirci, Ilaria Tinazzi, Ahmet Omma, Orhan Kucuksahin, Cem Ozisler, Sule Yavuz, Ozun Bayindir, Gezmis Kimyon, Atalay Dogru, Emine Figen Tarhan, Meryem Can, Levent Kilic, Mehmet Tuncay Duruoz, Kenan Aksu, Umut Kalyoncu & Sibel Zehra Aydin. (2020) Large joint and lower extremity involvement have higher impact on disease outcomes in oligoarticular psoriatic arthritis. International Journal of Rheumatic Diseases 23:8, pages 1094-1099.
Crossref
Crossref
Ana-Maria Orbai, Alexis Ogdie, Laure Gossec, William Tillett, Ying Ying Leung, Jingjing Gao, Mona Trivedi, Chantal Tasset, Luc Meuleners, Robin Besuyen, Thijs Hendrikx & Laura C Coates. (2020) Effect of filgotinib on health-related quality of life in active psoriatic arthritis: a randomized phase 2 trial (EQUATOR). Rheumatology 59:7, pages 1495-1504.
Crossref
Crossref
Laure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer, Maarten de Wit, Iain McInnes, Maxime Dougados, Jette Primdahl, Dennis G McGonagle, Daniel Aletaha, Andra Balanescu, Peter V Balint, Heidi Bertheussen, Wolf-Henning Boehncke, Gerd R Burmester, Juan D Canete, Nemanja S Damjanov, Tue Wenzel Kragstrup, Tore K Kvien, Robert B M Landewé, Rik Jozef Urbain Lories, Helena Marzo-Ortega, Denis Poddubnyy, Santiago Andres Rodrigues Manica, Georg Schett, Douglas J Veale, Filip E Van den Bosch, Désirée van der Heijde & Josef S Smolen. (2020) EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Annals of the Rheumatic Diseases 79:6, pages 700.1-712.
Crossref
Crossref
Maria Antonietta Barbieri, Giuseppe Cicala, Paola Maria Cutroneo, Elisabetta Gerratana, Caterina Palleria, Caterina De Sarro, Ada Vero, Luigi Iannone, Antonia Manti, Emilio Russo, Giovambattista De Sarro, Fabiola Atzeni & Edoardo Spina. (2020) Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study. Journal of Clinical Medicine 9:4, pages 1227.
Crossref
Crossref
Dafna Gladman, Peter Nash, Hitoshi Goto, Julie A Birt, Chen-Yen Lin, Ana-Maria Orbai & Tore K Kvien. (2020) Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis. RMD Open 6:1, pages e000928.
Crossref
Crossref
Philip J. Mease, Mei Liu, Sabrina Rebello, Hyungjoo Kang, Esther Yi, Yujin Park & Jeffrey D. Greenberg. (2019) Comparative Disease Burden in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Axial Spondyloarthritis: Data from Two Corrona Registries. Rheumatology and Therapy 6:4, pages 529-542.
Crossref
Crossref
Jon Lampa. (2019) Pain without inflammation in rheumatic diseases. Best Practice & Research Clinical Rheumatology 33:3, pages 101439.
Crossref
Crossref
Praveena Chiowchanwisawakit, Varalak Srinonprasert, Phakhamon Thaweeratthakul & Wanruchada Katchamart. (2019) Disease activity and functional status associated with health‐related quality of life and patient‐acceptable symptom state in patients with psoriatic arthritis in Thailand: A cross‐sectional study. International Journal of Rheumatic Diseases 22:4, pages 700-707.
Crossref
Crossref
Clémence Gorlier, Ana-Maria Orbai, Déborah Puyraimond-Zemmour, Laura C Coates, Uta Kiltz, Ying-Ying Leung, Penelope Palominos, Juan D Cañete, Rossana Scrivo, Andra Balanescu, Emmanuelle Dernis, Sandra Tälli, Adeline Ruyssen-Witrand, Martin Soubrier, Sibel Zehra Aydin, Lihi Eder, Inna Gaydukova, Ennio Lubrano, Umut Kalyoncu, Pascal Richette, M Elaine Husni, Maarten de Wit, Josef S Smolen & Laure Gossec. (2019) Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries. Annals of the Rheumatic Diseases 78:2, pages 201-208.
Crossref
Crossref
Philip Mease, Laura C Coates, Philip S Helliwell, Mykola Stanislavchuk, Anna Rychlewska-Hanczewska, Anna Dudek, Walid Abi-Saab, Chantal Tasset, Luc Meuleners, Pille Harrison, Robin Besuyen, Annegret Van der Aa, Neelufar Mozaffarian, Joy M Greer, Rebecca Kunder, Filip Van den Bosch & Dafna D Gladman. (2018) Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial. The Lancet 392:10162, pages 2367-2377.
Crossref
Crossref
Magdalena Krajewska-Włodarczyk, Agnieszka Owczarczyk-Saczonek & Waldemar Placek. (2018) Sleep disorders in patients with psoriatic arthritis and psoriasis. Rheumatology 56:5, pages 301-306.
Crossref
Crossref